Literature DB >> 6833796

Serum arabinitol concentrations and arabinitol/creatinine ratios in invasive candidiasis.

J W Gold, B Wong, E M Bernard, T E Kiehn, D Armstrong.   

Abstract

Serum arabinitol concentrations and arabinitol/creatinine ratios were determined in 25 cancer patients with invasive candidiasis, 73 severely ill cancer patients who did not have invasive candidiasis, and 15 uninfected patients with chronic renal failure. Elevated arabinitol concentrations were found in patients with renal failure and invasive candidiasis. Serum arabinitol concentrations exceeded 1.19 micrograms/ml in 13 of 18 patients with invasive candidiasis who were studied when renal function was normal and in three of 52 control patients. Among patients with renal failure, 10 of 14 with invasive candidiasis but only four of 36 control patients had serum arabinitol concentrations of greater than 5.85 micrograms/ml. Serum arabinitol and creatinine concentrations were strongly correlated. The arabinitol/ creatinine ratio exceeded 1.5 in 16 of 25 patients with invasive candidiasis but in only three of 88 control patients. Increased serum arabinitol concentrations appear to reflect increased production of arabinitol by yeast in individuals with invasive candidiasis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833796     DOI: 10.1093/infdis/147.3.504

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

Review 1.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

2.  Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera.

Authors:  M Manning-Zweerink; C S Maloney; T G Mitchell; H Weston
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients.

Authors:  L de Repentigny; L D Marr; J W Keller; A W Carter; R J Kuykendall; L Kaufman; E Reiss
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

4.  Comparison of serum mannan, arabinitol, and mannose in experimental disseminated candidiasis.

Authors:  L de Repentigny; R J Kuykendall; F W Chandler; J R Broderson; E Reiss
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

5.  Clinical correlations of serial quantitative blood cultures determined by lysis-centrifugation in patients with persistent septicemia.

Authors:  E Whimbey; B Wong; T E Kiehn; D Armstrong
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

6.  Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis.

Authors:  M E Bougnoux; C Hill; D Moissenet; M Feuilhade de Chauvin; M Bonnay; I Vicens-Sprauel; F Pietri; M McNeil; L Kaufman; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

7.  Candida detection system (CAND-TEC) to differentiate between Candida albicans colonization and disease.

Authors:  J C Fung; S T Donta; R C Tilton
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

Review 8.  New developments in the diagnosis of opportunistic fungal infection.

Authors:  V Hopwood; D W Warnock
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

9.  D-arabitol metabolism in Candida albicans: studies of the biosynthetic pathway and the gene that encodes NAD-dependent D-arabitol dehydrogenase.

Authors:  B Wong; J S Murray; M Castellanos; K D Croen
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

10.  Estimations of serum arabinitol for diagnosing invasive candidosis.

Authors:  A G Deacon
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.